| 27630305 | Characterization of CD44+ALDH1+Ki-67- Cells in Non-malignant and Neoplastic Lesions of the Breast. | Anticancer Res | 2016 Sep | DA Cruz Paula A | - |
| 27863473 | ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer. | BMC Cancer | 2016 Nov 18 | Magnusson K | - |
| 24200480 | Diffusion-weighted imaging of prostate cancer on 3T MR: Relationship between apparent diffusion coefficient values and Ki-67 expression. | Acad Radiol | 2013 Dec | Zhang J | doi: 10.1016/j.acra.2013.09.007. |
| 28235003 | P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients. | PLoS One | 2017 Feb 24 | Pan Y | doi: 10.1371/journal.pone.0172324 |
| 22890751 | Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancer. | Breast Cancer Res Treat | 2012 Sep | Delpech Y | doi: 10.1007/s10549-012-2194-2 |
| 19690767 | Tumor biomarkers in cervical cancer: focus on Ki-67 proliferation factor and E-cadherin expression. | Rom J Morphol Embryol | 2009 | Ancua E | - |
| 17377809 | Prognostic value of PIK3CA and phosphorylated AKT expression in ovarian cancer. | Virchows Arch | 2007 Apr | Woenckhaus J | - |
| 28188752 | Comparison of 5 Ki-67 antibodies regarding reproducibility and capacity to predict prognosis in breast cancer: does the antibody matter? | Hum Pathol | 2017 Jul | ??cs B | doi: 10.1016/j.humpath.2017.01.011 |
| 20450760 | [Expression of HER2/neu in meningiomas: an immunohistochemistry and fluorescence in situ hybridization study]. | Zhonghua Bing Li Xue Za Zhi | 2010 Mar | Wang CL | - |
| 19818763 | Minichromosome maintenance protein 3 is a candidate proliferation marker in papillary thyroid carcinoma. | Exp Mol Pathol | 2010 Feb | Lee YS | doi: 10.1016/j.yexmp.2009.09.015 |
| 18705408 | Histopathological parameters with Ki-67 and bcl-2 in the prognosis of meningiomas according to WHO 2000 classification. | Tumori | 2008 May-Jun | Uz??m N | - |
| 30176814 | Relationship between the Ki67 index and its area based approximation in breast cancer. | BMC Cancer | 2018 Sep 3 | Niazi MKK | doi: 10.1186/s12885-018-4735-5. |
| 11759064 | Tissue microarray technique in soft tissue sarcoma: immunohistochemical Ki-67 expression in malignant fibrous histiocytoma. | Appl Immunohistochem Mol Morphol | 2001 Dec | Engellau J | - |
| 19160064 | Caveolin-1 overexpression correlates with tumour progression markers in pancreatic ductal adenocarcinoma. | J Mol Histol | 2009 Feb | Tanase CP | doi: 10.1007/s10735-008-9209-7 |
| 22995634 | Impact of the epithelial dysplasia grading and Ki67 proliferation index in the adjacent non-malignant mucosa on recurrence and survival in head and neck squamous cell carcinoma. | Pathol Res Pract | 2012 Nov 15 | Pereira CS | doi: 10.1016/j.prp.2012.08.002 |
| 18095132 | Analysis of immunohistochemical expression of p53 and the proliferation marker Ki-67 antigen in skull base chordomas: relationships between their expression and prognosis. | Brain Tumor Pathol | 2007 | Sakai K | - |
| 15214825 | Granular cell tumor: immunohistochemical assessment of inhibin-alpha, protein gene product 9.5, S100 protein, CD68, and Ki-67 proliferative index with clinical correlation. | Arch Pathol Lab Med | 2004 Jul | Le BH | - |
| 18018472 | MIB-1 immunolabeling: a valuable marker in prediction of benign recurring meningiomas. | Neuropathology | 2007 Oct | Vankalakunti M | - |
| 22040408 | Relationship between magnetic resonance imaging and molecular pathology in patients with glioblastoma multiforme. | Chin Med J (Engl) | 2011 Sep | Li WB | - |
| 24384677 | Characterizing invading glioma cells based on IDH1-R132H and Ki-67 immunofluorescence. | Brain Tumor Pathol | 2014 Oct | Sabit H | doi: 10.1007/s10014-013-0172-y |
| 20868604 | [Infection of human papillomavirus 16/18 DNA in patients with head and neck squamous cell carcinoma and its relationship with expression of Ki-67 and P53 protein]. | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | 2010 Aug | Zhang JL | doi: 10.3881/j.issn.1000-503X.2010.04.015. |
| 18572327 | Relationship of Ki67, TP53, MDM-2 and BCL-2 expressions with WHO 1973 and WHO/ISUP grades, tumor category and overall patient survival in urothelial tumors of the bladder. | Pathol Res Pract | 2008 | Gn??l II | doi: 10.1016/j.prp.2008.03.011 |
| 25313763 | The expression of MMP-2 and Ki-67 in head and neck melanoma, and their correlation with clinic-pathologic indices. | J Cancer Res Ther | 2014 Jul-Sep | Kamyab-Hesari K | doi: 10.4103/0973-1482.138122. |
| 25012947 | Diagnostic caveats of immunoreactivity for Ki67 and chromogranin A in hyalinizing trabecular tumour of the thyroid. | J Clin Pathol | 2014 Sep | Park HS | - |
| 17848143 | Non-small cell lung carcinoma: cyclin D1, bcl-2, p53, Ki-67 and HER-2 proteins expression in resected tumors. | Bosn J Basic Med Sci | 2007 Aug | Radovi S | - |
| 27276745 | Correlation between Serum SCCA and CYFRA 2 1-1, Tissue Ki-67, and Clinicopathological Factors in Patients with Esophageal Squamous Cell Carcinoma. | J Med Assoc Thai | 2016 Mar | Sunpaweravong S | - |
| 19130399 | Analysis of pRb, p16INK4A proteins and proliferating antigens: PCNA, Ki-67 and MCM5 expression in aggressive fibromatosis (desmoid tumor). | Histol Histopathol | 2009 Mar | Stalinska L | doi: 10.14670/HH-24.299. |
| 21655654 | Endometrial carcinomas: correlation between ER, PR, Ki67 status and histopathological prognostic parameters. | Rom J Morphol Embryol | 2011 | Stoian SC | - |
| 25120774 | Possible prognostic significance of p53, cyclin D1 and Ki-67 in the second primary malignancy of patients with double primary malignancies. | Int J Clin Exp Pathol | 2014 Jun 15 | Dong M | - |
| 26659720 | Increased expression of ERCC2 gene in head and neck cancer is associated with aggressive tumors: a systematic review and case-control study. | Int J Biol Markers | 2016 Feb 28 | Zafeer M | doi: 10.5301/jbm.5000186. |
| 11570981 | Lack of correlation between Ki-67 labelling index and tumor size of anterior pituitary adenomas. | BMC Cancer | 2001 | Mastronardi L | - |
| 18510217 | [Relevance between clinical behavior and bionomical findings of acoustic neuromas]. | Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi | 2008 Feb | Yang SM | - |
| 20483025 | Labeling index in pituitary adenomas evaluated by means of MIB-1: is there a prognostic role? A critical review. | Neurol Res | 2010 Dec | de Aguiar PH | doi: 10.1179/016164110X12670144737855 |
| 20694513 | MCM-2 and MCM-5 expression in gastric adenocarcinoma: clinical significance and comparison with Ki-67 proliferative marker. | Dig Dis Sci | 2011 Mar | Giaginis C | doi: 10.1007/s10620-010-1348-5 |
| 21424069 | Immunohistochemical nuclear staining for p53, PCNA, Ki-67 and bcl-2 in different histologic variants of basal cell carcinoma. | Rom J Morphol Embryol | 2011 | Mateoiu C | - |
| 26188382 | Thyroid H??rthle cell tumors: research of potential markers of malignancy. | J Endocrinol Invest | 2016 Feb | Donatini G | doi: 10.1007/s40618-015-0356-x |
| 20627009 | [Relationship between Ki67 expression and tumor response to neoadjuvant chemotherapy with anthracyclines plus taxanes in breast cancer]. | Zhonghua Wai Ke Za Zhi | 2010 Mar 15 | Xu L | - |
| 26459875 | Ki-67 labeling index affects tumor infiltration patterns of lung squamous cell carcinoma. | Mol Med Rep | 2015 Nov | Masuda D | doi: 10.3892/mmr.2015.4354 |
| 21819622 | Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies. | BMC Cancer | 2011 Aug 7 | Romero Q | doi: 10.1186/1471-2407-11-341. |
| 26619927 | Prognostic value of Ki-67 in solid pseudopapillary tumor of the pancreas: Huashan experience and systematic review of the literature. | Surgery | 2016 Apr | Yang F | doi: 10.1016/j.surg.2015.10.018 |
| 26456310 | Correlations between ADC values and molecular markers of Ki-67 and HIF-1α in hepatocellular carcinoma. | Eur J Radiol | 2015 Dec | Huang Z | doi: 10.1016/j.ejrad.2015.09.013 |
| 23382631 | Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumors. | World J Gastroenterol | 2013 Jan 28 | Belev B | doi: 10.3748/wjg.v19.i4.523. |
| 23805466 | [Ki-67 and matrix metalloproteinase-9 expression in the follicular cyst, keratocystic odontogenic tumor, and ameloblastoma]. | Arkh Patol | 2013 Jan-Feb | Bibichenko II | - |
| 17594714 | Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other. | Cancer | 2007 Aug 15 | Tollefson MK | - |
| 21524841 | MicroRNA-519d targets MKi67 and suppresses cell growth in the hepatocellular carcinoma cell line QGY-7703. | Cancer Lett | 2011 Aug 28 | Hou YY | doi: 10.1016/j.canlet.2011.04.002 |
| 25381338 | Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer. | Clin Cancer Res | 2015 Jun 1 | Paoletti C | doi: 10.1158/1078-0432.CCR-14-1913 |
| 22531522 | Correlation of fluorodeoxyglucose uptake and tumor-proliferating antigen Ki-67 in lymphomas. | J Cancer Res Ther | 2012 Jan-Mar | Shou Y | doi: 10.4103/0973-1482.95182. |
| 19559929 | Platelet-derived growth factor expression correlates with tumor grade and proliferative activity in human oligodendrogliomas. | Surg Neurol | 2009 Jul | Majumdar K | doi: 10.1016/j.surneu.2008.10.001. |
| 24121170 | Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate. | Am J Surg Pathol | 2013 Nov | McCall CM | doi: 10.1097/PAS.0000000000000089. |
| 26954364 | Risk Factors Associated with Discordant Ki-67 Levels between Preoperative Biopsy and Postoperative Surgical Specimens in Breast Cancers. | PLoS One | 2016 Mar 8 | Kim HS | doi: 10.1371/journal.pone.0151054 |
| 17525638 | Cell membrane reactivity of MIB-1 antibody to Ki67 in human tumors: fact or artifact? | Appl Immunohistochem Mol Morphol | 2007 Jun | Leonardo E | - |
| 26096243 | Correlation of astrocyte elevated gene-1, basic-fibroblast growth factor, beta-catenin, Ki-67, tumor necrosis factor-alfa with prognostic parameters in ductal carcinomas and ductal intraepithelial neoplasms. | Niger J Clin Pract | 2015 Sep-Oct | Erdem H | doi: 10.4103/1119-3077.158961. |
| 29432944 | Expression of Matrix Metalloproteinase-9, Pituitary Tumor Transforming Gene, High Mobility Group A 2, and Ki-67 in Adrenocorticotropic Hormone-Secreting Pituitary Tumors and Their Association with Tumor Recurrence. | World Neurosurg | 2018 May | Liu X | doi: 10.1016/j.wneu.2018.01.214 |
| 28965621 | Expression of pRb, Ki67 and HER 2/neu in gastric carcinomas: Relation to different histopathological grades and stages. | Ann Diagn Pathol | 2017 Oct | Abdel-Aziz A | doi: 10.1016/j.anndiagpath.2017.05.003 |
| 29351120 | Grading Using Ki-67 Index and Mitotic Rate Increases the Prognostic Accuracy of Pancreatic Neuroendocrine Tumors. | Pancreas | 2018 Mar | Philips P | doi: 10.1097/MPA.0000000000000990. |
| 30103737 | Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients. | Respir Res | 2018 Aug 13 | Wei DM | doi: 10.1186/s12931-018-0843-7. |
| 29480449 | Assessment of the predictive role of pretreatment Ki-67 and Ki-67 changes in breast cancer patients receiving neoadjuvant chemotherapy according to the molecular classification: a retrospective study of 1010 patients. | Breast Cancer Res Treat | 2018 Jul | Chen R | doi: 10.1007/s10549-018-4730-1 |
| 18005189 | The relationship between tumour proliferative activity, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. | Colorectal Dis | 2008 Sep | Canna K | - |
| 24507671 | Correlations of β-catenin, Ki67 and Her-2/neu with gastric cancer. | Asian Pac J Trop Med | 2014 Apr | Wu HW | doi: 10.1016/S1995-7645(14)60033-X. |
| 19773751 | Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis. | Br J Cancer | 2009 Oct 20 | Fluge | doi: 10.1038/sj.bjc.6605333 |
| 28640099 | Prognostic impact of Ki-67 in patients with gastric cancer-the importance of depth of invasion and histologic differentiation. | Medicine (Baltimore) | 2017 Jun | Ko GH | doi: 10.1097/MD.0000000000007181. |
| 23382998 | New insight into Ki67 expression at the invasive front in breast cancer. | PLoS One | 2013 | Gong P | doi: 10.1371/journal.pone.0054912 |
| 26241661 | Distinguishing Low-Risk Luminal A Breast Cancer Subtypes with Ki-67 and p53 Is More Predictive of Long-Term Survival. | PLoS One | 2015 Aug 4 | Lee SK | doi: 10.1371/journal.pone.0124658 |
| 25807305 | The prognostic role of Ki-67/MIB-1 in cervical cancer: a systematic review with meta-analysis. | Med Sci Monit | 2015 Mar 25 | Pan D | doi: 10.12659/MSM.892807. |
| 23003335 | p16(INK4a) /Ki-67 dual labelling as a marker for the presence of high-grade cancer cells or disease progression in urinary cytopathology. | Cytopathology | 2013 Oct | Piaton E | doi: 10.1111/j.1365-2303.2012.01008.x |
| 26925684 | Response of Triple Negative Breast Cancer to Neoadjuvant Chemotherapy: Correlation between Ki-67 Expression and Pathological Response. | Asian Pac J Cancer Prev | 2016 | Elnemr GM | - |
| 16171567 | Modulation of Ki-67 expression and morphological changes induced by gef gene in MCF-7 human breast cancer cells. | Cell Mol Biol (Noisy-le-grand) | 2005 Sep 2 | Boulaiz H | - |
| 27514658 | ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC). | Virchows Arch | 2016 Nov | Breyer J | - |
| 18301453 | The role of cyclins and cyclins inhibitors in the multistep process of HPV-associated cervical carcinoma. | J Egypt Natl Canc Inst | 2006 Dec | Bahnassy AA | - |
| 26076967 | Association between androgen receptor expression, Ki-67 and the 21-gene recurrence score in non-metastatic, lymph node-negative, estrogen receptor-positive and HER2-negative breast cancer. | J Clin Pathol | 2015 Oct | Vera-Badillo FE | doi: 10.1136/jclinpath-2015-203012 |
| 11857304 | p53 and Ki-67 as markers of radioresistance in head and neck carcinoma. | Cancer | 2002 Feb 1 | Couture C | - |
| 21111561 | Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer. | Eur J Surg Oncol | 2011 Feb | Tanei T | doi: 10.1016/j.ejso.2010.10.009 |
| 23970015 | Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial. | Ann Oncol | 2013 Nov | Denkert C | doi: 10.1093/annonc/mdt350 |
| 26261629 | Detecting of gastric cancer by Bcl-2 and Ki67. | Int J Clin Exp Pathol | 2015 Jun 1 | Zhou Y | - |
| 25170613 | Progesterone receptor status and Ki-67 index may predict early relapse in luminal B/HER2 negative breast cancer patients: a retrospective study. | PLoS One | 2014 Aug 29 | Zong Y | doi: 10.1371/journal.pone.0095629 |
| 20840814 | [Expression of carbonic anhydrase IX in NSCLC and its relationship with VEGF and Ki67 expression]. | Zhongguo Fei Ai Za Zhi | 2010 Sep | Zhao X | doi: 10.3779/j.issn.1009-3419.2010.09.05. |
| 18312749 | Ki-67 and PCNA expression in prostate cancer and benign prostatic hyperplasia. | Clin Invest Med | 2008 | Zhong W | - |
| 12434121 | p53 and Ki-67 expression in epithelial gastric dysplasia and in gastric cancer. | Panminerva Med | 2002 Dec | Testino G | - |
| 20010526 | Correlation between histological type and immunohistochemical profile of prostate cancer and gleason scale gradation. | Exp Oncol | 2009 Dec | Iemelynova AA | - |
| 25778295 | Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer. | J BUON | 2015 Jan-Feb | Avci N | - |
| 15591788 | Expression of estrogen receptor-alpha and Ki67 in relation to pathological and molecular features in early-onset infiltrating ductal carcinoma. | J Biomed Sci | 2004 Nov-Dec | Ding SL | - |
| 24486077 | Prostate cancer Ki-67 (MIB-1) expression, perineural invasion, and gleason score as biopsy-based predictors of prostate cancer mortality: the Mayo model. | Mayo Clin Proc | 2014 Mar | Tollefson MK | doi: 10.1016/j.mayocp.2013.12.001 |
| 24189270 | Quantitative assessment Ki-67 score for prediction of response to neoadjuvant chemotherapy in breast cancer. | Lab Invest | 2014 Jan | Brown JR | doi: 10.1038/labinvest.2013.128 |
| 15931389 | Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. | J Clin Invest | 2005 Jun | Glinsky GV | - |
| 20030864 | Who would have thought it! Influence on outcome of radiotherapy, Ki67 and stroma. Introduction to Session 5. | Breast Cancer Res | 2009 | Rodger A | doi: 10.1186/bcr2432 |
| 24949917 | The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypes. | Anticancer Drugs | 2014 Sep | Stathopoulos GP | doi: 10.1097/CAD.0000000000000123. |
| 25790540 | Clinicopathological importance of Ki-67, p27, and p53 expression in gastric cancer. | Turk J Med Sci | 2015 | alik M | - |
| 19774459 | Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasia. | Breast Cancer Res Treat | 2010 Jun | Santisteban M | doi: 10.1007/s10549-009-0534-7 |
| 26458958 | Evaluation of an epithelial plasticity biomarker panel in men with localized prostate cancer. | Prostate Cancer Prostatic Dis | 2016 Mar | Armstrong AJ | doi: 10.1038/pcan.2015.46 |
| 23030583 | Immunohistological expression of HIF-1α, GLUT-1, Bcl-2 and Ki-67 in consecutive biopsies during chemoradiotherapy in patients with rectal cancer. | APMIS | 2013 Feb | Havelund BM | doi: 10.1111/j.1600-0463.2012.02949.x |
| 23614934 | A mutation in the 5' untranslated region of the BRCA1 gene in sporadic breast cancer causes downregulation of translation efficiency. | J Int Med Res | 2007 Jul-Aug | Wang J | - |
| 21629784 | A tri-marker proliferation index predicts biochemical recurrence after surgery for prostate cancer. | PLoS One | 2011 | Malhotra S | doi: 10.1371/journal.pone.0020293 |
| 19470936 | MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02. | J Clin Oncol | 2009 Jul 1 | Khor LY | doi: 10.1200/JCO.2008.19.8267 |
| 23818355 | Relationship of TP53 and Ki67 expression in bladder cancer under WHO 2004 classification. | J BUON | 2013 Apr-Jun | Wang L | - |
| 11925591 | The abnormal expression of retinoic acid receptor-beta, p 53 and Ki67 protein in normal, premalignant and malignant esophageal tissues. | World J Gastroenterol | 2002 Apr | Xu M | - |
| 18690204 | Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA. | Cancer Gene Ther | 2009 Jan | Zheng JN | doi: 10.1038/cgt.2008.61 |
| 25400769 | Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy. | Int J Clin Exp Pathol | 2014 Sep 15 | Tan QX | - |
| 27175798 | Immunocytochemical study of TOP2A and Ki-67 in cervical smears from women under routine gynecological care. | J Biomed Sci | 2016 May 12 | Peres AL | doi: 10.1186/s12929-016-0258-z. |
| 25932921 | An interobserver reproducibility analysis of Ki67 visual assessment in breast cancer. | PLoS One | 2015 May 1 | Shui R | doi: 10.1371/journal.pone.0125131 |
| 24403473 | Association between tumor size and immunohistochemical expression of Ki-67, p53 and BCL2 in a node-negative breast cancer population selected from a breast cancer screening program. | Anticancer Res | 2014 Jan | Gonz??lez-Sistal A | - |
| 24870756 | Associations between mammography and ultrasound imaging features and molecular characteristics of triple-negative breast cancer. | Asian Pac J Cancer Prev | 2014 | Li B | - |
| 21366896 | Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis. | Breast Cancer Res | 2011 Mar 2 | Keam B | doi: 10.1186/bcr2834. |
| 23137549 | Clinical impact of ki-67 labeling index in non-small cell lung cancer. | Lung Cancer | 2013 Jan | Jakobsen JN | doi: 10.1016/j.lungcan.2012.10.008 |
| 23812670 | Ki67 measured after neoadjuvant chemotherapy for primary breast cancer. | Clin Cancer Res | 2013 Aug 15 | von Minckwitz G | doi: 10.1158/1078-0432.CCR-12-3628 |
| 24403187 | The prognostic value of Ki67 in systemically untreated patients with node-negative breast cancer. | J Clin Pathol | 2014 Mar | Pathmanathan N | doi: 10.1136/jclinpath-2013-201793 |
| 26742937 | Ki-67 is a prognostic marker for hormone receptor positive tumors. | Clin Transl Oncol | 2016 Oct | P??rez-L??pez ME | doi: 10.1007/s12094-015-1472-y |
| 19093259 | Ki67 and salivary cancer. | Cancer Invest | 2008 Dec | Ben-Izhak O | doi: 10.1080/07357900802088968. |
| 26420767 | The importance of tissue handling of surgically removed breast cancer for an accurate assessment of the Ki-67 index. | J Clin Pathol | 2016 Mar | Arima N | doi: 10.1136/jclinpath-2015-203174 |
| 23526930 | Long-term prognostic performance of Ki67 rate in early stage, pT1-pT2, pN0, invasive breast carcinoma. | PLoS One | 2013 | Reyal F | doi: 10.1371/journal.pone.0055901 |
| 26060263 | Menstrual cycle could affect Ki67 expression in estrogen receptor-positive breast cancer patients. | J Clin Pathol | 2015 Oct | Horimoto Y | doi: 10.1136/jclinpath-2015-203085 |
| 20686376 | Selected immunohistochemical prognostic factors in endometrial cancer. | Int J Gynecol Cancer | 2010 May | Markova I | doi: 10.1111/IGC.0b013e3181d80ac4. |
| 21881319 | Ki-67 labeling index is associated with recurrence after segmentectomy under video-assisted thoracoscopic surgery in stage I non-small cell lung cancer. | Ann Thorac Cardiovasc Surg | 2011 | Yamashita S | - |
| 21809665 | [Ki-67 expression, thymidine phosphorylase and PTEN in intraepithelial cervical carcinoma]. | Vopr Onkol | 2011 | Korolenkova LI | - |
| 23286956 | [Ki67 in young patients with breast cancer]. | Gynecol Obstet Fertil | 2013 Jan | Vasseur F | doi: 10.1016/j.gyobfe.2012.11.005 |
| 26214624 | Importance of Ki-67 in human epidermal growth factor receptor 2 positive breast cancer. | J BUON | 2015 May-Jun | Erdogan B | - |
| 18592370 | The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer. | Breast Cancer Res Treat | 2009 Jul | Jones RL | doi: 10.1007/s10549-008-0081-7 |
| 23594232 | Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study. | APMIS | 2013 Dec | Heeran MC | doi: 10.1111/apm.12071 |
| 23235554 | Retrospective analysis of risk factors for central nervous system metastases in operable breast cancer: effects of biologic subtype and Ki67 overexpression on survival. | Oncology | 2013 | Ishihara M | doi: 10.1159/000345321 |
| 18727426 | [Significance of the expression of nucleolar argyrophilic proteins and antigen Ki-67 in the evaluation of cell proliferative activity and in the prediction of minimal (T1) lung cancer]. | Arkh Patol | 2008 May-Jun | Rakhlin NT | - |
| 23184081 | Different prognostic significance of Ki-67 change between pre- and post-neoadjuvant chemotherapy in various subtypes of breast cancer. | Breast Cancer Res Treat | 2013 Jan | Matsubara N | doi: 10.1007/s10549-012-2344-6 |
| 27509952 | Expression of the p16 and Ki67 in Cervical Squamous Intraepithelial Lesions and Cancer. | Asian Pac J Cancer Prev | 2016 | Kanthiya K | - |
| 26039245 | Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients. | PLoS One | 2015 Jun 3 | Ricciardi GR | doi: 10.1371/journal.pone.0128368 |
| 22534537 | Clinical significance of Smac and Ki-67 expression in pancreatic cancer. | Hepatogastroenterology | 2012 Nov-Dec | Hu HY | - |
| 19050681 | Utility of tissue microarrays for profiling prognostic biomarkers in clinically localized prostate cancer: the expression of BCL-2, E-cadherin, Ki-67 and p53 as predictors of biochemical failure after radical prostatectomy with nested control for clinical and pathological risk factors. | Asian J Androl | 2009 Jan | Nariculam J | doi: 10.1038/aja.2008.22 |
| 18762814 | Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance. | Prostate Cancer Prostatic Dis | 2009 | Jhavar S | doi: 10.1038/pcan.2008.47 |
| 21680106 | Differential expression of DUSP6 with expression of ERK and Ki-67 in non-small cell lung carcinoma. | Pathol Res Pract | 2011 Jul 15 | Lee H | doi: 10.1016/j.prp.2011.05.004 |
| 24498305 | Prognostic value of Ki-67 in breast cancer patients with positive axillary lymph nodes: a retrospective cohort study. | PLoS One | 2014 Feb 3 | Li FY | doi: 10.1371/journal.pone.0087264 |
| 16097446 | p27(kip1) and Ki-67 (MIB1) immunohistochemical expression in radical prostatectomy specimens of patients with clinically localized prostate cancer. | In Vivo | 2005 Sep-Oct | Revelos K | - |
| 20103652 | SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation. | Cancer Res | 2010 Feb 1 | Thomsen MK | doi: 10.1158/0008-5472.CAN-09-2370 |
| 23674192 | Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry. | Breast Cancer Res Treat | 2013 Jun | Inwald EC | doi: 10.1007/s10549-013-2560-8 |
| 19690760 | P53, p63 and Ki-67 assessment in HPV-induced cervical neoplasia. | Rom J Morphol Embryol | 2009 | Vasilescu F | - |
| 23359198 | Expression of Ki-67 (MIB-1) and GLUT-1 proteins in non-advanced prostatic cancer. | Pol J Pathol | 2012 Dec | Luczynska E | - |
| 21080107 | CK5/6, EGFR, Ki-67, cyclin D1, and nm23-H1 protein expressions as predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer patients. | Med Oncol | 2011 Dec | Li XR | doi: 10.1007/s12032-010-9742-6 |
| 26978017 | [Prognostic values of the clinical, morphological and molecular biological characteristics of colon adenocarcinoma]. | Arkh Patol | 2015 Sep-Oct | Raskin GA | doi: 10.17116/patol201577526-30. |
| 26472563 | Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triple-negative breast cancer: a retrospective study on 129 cases. | BMC Cancer | 2015 Oct 15 | Zhang Y | doi: 10.1186/s12885-015-1694-y. |
| 17143016 | Ki-67, p53, ER receptors, ploidy and S phase as long-term prognostic factors in T1 node-negative breast cancer. | Tumour Biol | 2007 | Railo M | - |
| 19935641 | The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer. | Mod Pathol | 2010 Feb | Klintman M | doi: 10.1038/modpathol.2009.167 |
| 25967708 | Relationship between CD4+CD25+ Treg and expression of HIF-1α and Ki-67 in NSCLC patients. | Eur Rev Med Pharmacol Sci | 2015 Apr | He LY | - |
| 23818347 | Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherapy. | J BUON | 2013 Apr-Jun | Dede DS | - |
| 19340613 | Immunohistochemical analysis revealed CD34 and Ki67 protein expression as significant prognostic factors in colorectal cancer. | Med Oncol | 2010 Jun | Ma YL | doi: 10.1007/s12032-009-9210-3 |
| 26206765 | The region-of-interest size impacts on Ki67 quantification by computer-assisted image analysis in breast cancer. | Hum Pathol | 2015 Sep | Christgen M | doi: 10.1016/j.humpath.2015.05.016 |
| 23139965 | The prognostic value of the P53 protein and the Ki67 marker in breast cancer patients. | J Pak Med Assoc | 2012 Sep | Golmohammadi R | - |
| 25339008 | Prognostic significance of expression of CD133 and Ki-67 in gastric cancer. | Asian Pac J Cancer Prev | 2014 | Saricanbaz I | - |
| 25684532 | Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis. | Asian Pac J Cancer Prev | 2015 | Yan J | - |
| 25863475 | Ki-67 expression in sclerosing adenosis and adjacent normal breast terminal ductal lobular units: a nested case-control study from the Mayo Benign Breast Disease Cohort. | Breast Cancer Res Treat | 2015 May | Nassar A | doi: 10.1007/s10549-015-3370-y |
| 17805549 | Survivin, p53, and Ki-67 as predictors of histopathologic response in locally advanced rectal cancer treated with preoperative chemoradiotherapy. | Int J Colorectal Dis | 2008 Jan | Terzi C | - |
| 20181625 | Molecular profiling using tissue microarrays as a tool to identify predictive biomarkers in laryngeal cancer treated with radiotherapy. | Cancer Genomics Proteomics | 2010 Jan-Feb | Holgersson G | - |
| 16479062 | Prognostic value of immunohistochemical staining of p53, bcl-2, and Ki-67 in small cell lung cancer. | J Korean Med Sci | 2006 Feb | Paik KH | - |
| 26633571 | The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence. | JAMA Oncol | 2016 Feb | Ignatiadis M | doi: 10.1001/jamaoncol.2015.4377. |
| 26070608 | Comparison of digital image analysis and visual scoring of KI-67 in prostate cancer prognosis after prostatectomy. | Diagn Pathol | 2015 Jun 13 | Desmeules P | doi: 10.1186/s13000-015-0294-0. |
| 14674120 | [Comparative studies of K1-67 expression between the primary tumor and breast cancer metastases to regional lymph nodes]. | Ginekol Pol | 2003 Sep | Koda M | - |
| 24403472 | Prognostic significance of Ki-67 in chemotherapy-naive breast cancer patients with 10-year follow-up. | Anticancer Res | 2014 Jan | Nishimiya H | - |
| 20030866 | Who would have thought a single Ki67 measurement would predict long-term outcome? | Breast Cancer Res | 2009 | Dowsett M | doi: 10.1186/bcr2434 |
| 11839580 | Breast cancer risk in usual ductal hyperplasia is defined by estrogen receptor-alpha and Ki-67 expression. | Am J Pathol | 2002 Feb | Shaaban AM | - |
| 17885492 | The clinical importance of Ki-67, p16, p14, and p57 expression in patients with advanced ovarian carcinoma. | Int J Gynecol Pathol | 2007 Oct | Khouja MH | - |
| 25600243 | High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer. | Clin Breast Cancer | 2015 Jun | Nishimukai A | doi: 10.1016/j.clbc.2014.12.007 |
| 24360660 | Ki-67 is an independent indicator in non-muscle invasive bladder cancer (NMIBC); combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC. | Urol Oncol | 2014 Jan | Ding W | doi: 10.1016/j.urolonc.2013.05.004. |
| 21354936 | [Correlation of CerbB-2 to Ki-67 and P53 expressions in hormone-independent breast cancer]. | Nan Fang Yi Ke Da Xue Xue Bao | 2011 Feb | Fang Q | - |
| 17065089 | Difference in Ki67 and thymidylate synthase expression in primary tumour compared with metastatic nodes in breast cancer patients. | Nucleosides Nucleotides Nucleic Acids | 2006 | Calascibetta A | - |
| 26281861 | High Ki67 expression is an independent good prognostic marker in colorectal cancer. | J Clin Pathol | 2016 Mar | Melling N | doi: 10.1136/jclinpath-2015-202985 |
| 23096218 | Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial. | Cancer Chemother Pharmacol | 2013 Jan | Pliarchopoulou K | doi: 10.1007/s00280-012-2002-z |
| 19436038 | Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. | J Natl Cancer Inst | 2009 May 20 | Cheang MC | doi: 10.1093/jnci/djp082 |
| 28075166 | The predictive value of Ki-67 before neoadjuvant chemotherapy for breast cancer: a systematic review and meta-analysis. | Future Oncol | 2017 Apr | Chen X | doi: 10.2217/fon-2016-0420 |
| 28373466 | A Retrospective Analysis of Ki-67 Index and its Prognostic Significance in Over 800 Primary Breast Cancer Cases. | Anticancer Res | 2017 Apr | Thangarajah F | - |
| 27284123 | Clinicopathological Significance of the Proliferation Markers Ki67, RacGAP1, and Topoisomerase 2 Alpha in Breast Cancer. | Int J Surg Pathol | 2016 Oct | ahin S | doi: 10.1177/1066896916653211 |
| 27163153 | Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models. | PLoS One | 2016 May 10 | Yang B | doi: 10.1371/journal.pone.0155145 |
| 26439929 | PSMB4 expression associates with epithelial ovarian cancer growth and poor prognosis. | Arch Gynecol Obstet | 2016 Jun | Liu R | doi: 10.1007/s00404-015-3904-x |
| 28651488 | Thymidine kinase 1 expression in ovarian serous adenocarcinoma is superior to Ki-67: A new prognostic biomarker. | Tumour Biol | 2017 Jun | Wang J | doi: 10.1177/1010428317706479. |
| 28502582 | Upregulation of RAD51 expression is associated with progression of thyroid carcinoma. | Exp Mol Pathol | 2017 Jun | Sarwar R | doi: 10.1016/j.yexmp.2017.05.001 |
| 27756439 | Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups. | Breast Cancer Res | 2016 Oct 18 | Abubakar M | - |
| 28237784 | Differences in Ki67 expressions between pre- and post-neoadjuvant chemotherapy specimens might predict early recurrence of breast cancer. | Hum Pathol | 2017 May | Tokuda E | doi: 10.1016/j.humpath.2017.02.005 |
| 28088868 | Prognostic values of Ki-67 in neoadjuvant setting for breast cancer: a systematic review and meta-analysis. | Future Oncol | 2017 May | Li L | doi: 10.2217/fon-2016-0428 |
| 26272457 | Analysis of NSCLC tumour heterogeneity, proliferative and 18F-FDG PET indices reveals Ki67 prognostic role in adenocarcinomas. | Histopathology | 2016 Apr | Del Gobbo A | doi: 10.1111/his.12808 |
| 28490348 | An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper. | Breast Cancer Res | 2017 May 11 | Varga Z | doi: 10.1186/s13058-017-0848-z. |
| 27588487 | p16/Ki-67 co-expression associates high risk human papillomavirus persistence and cervical histopathology: a 3-year cohort study in China. | Oncotarget | 2016 Oct 4 | Yu LL | doi: 10.18632/oncotarget.11705. |
| 29491110 | Ki-67 and Survivin as Predictive Factors for Rectal Cancer Treated with Preoperative Chemoradiotherapy. | Anticancer Res | 2018 Mar | Yoshikawa K | - |
| 28061893 | Prognostic significance of Ki67 in Chinese women diagnosed with ER+/HER2- breast cancers by the 2015St. Gallen consensus classification. | BMC Cancer | 2017 Jan 6 | Hu Y | doi: 10.1186/s12885-016-3021-7. |
| 28824297 | Over-Expression of Alpha-Enolase as a Prognostic Biomarker in Patients with Pancreatic Cancer. | Int J Med Sci | 2017 Jun 22 | Sun L | doi: 10.7150/ijms.18736 |
| 28648414 | Prognostic role of Ki-67 score in localized prostate cancer: A systematic review and meta-analysis. | Urol Oncol | 2017 Aug | Berlin A | doi: 10.1016/j.urolonc.2017.05.004 |
| 28425014 | Clinicopathological and prognostic significance of Ki-67 immunohistochemical expression of distant metastatic lesions in patients with metastatic breast cancer. | Breast Cancer | 2017 Nov | Inari H | doi: 10.1007/s12282-017-0774-z |
| 29104470 | Critical Role of p53 and K-ras in the Diagnosis of Early Colorectal Cancer: a One-year, Single-center Analysis. | Int J Med Sci | 2017 Sep 13 | Lu HY | doi: 10.7150/ijms.20538 |
| 28561880 | Meta-analysis of prognostic role of Ki-67 labeling index in gastric carcinoma. | Int J Biol Markers | 2017 Oct 31 | Pyo JS | doi: 10.5301/ijbm.5000277. |
| 29895125 | Clinical efficacy of p16/Ki-67 dual-stained cervical cytology in secondary prevention of cervical cancer. | Pol J Pathol | 2018 | Celewicz A | doi: 10.5114/pjp.2018.75335. |
| 28589765 | Prognostic value of Ki-67 expression in patients with extensive-stage small cell lung cancer. | Future Oncol | 2017 Jun | Pei R | doi: 10.2217/fon-2016-0542 |
| 29506507 | Ki-67 expression predicts biochemical recurrence after radical prostatectomy in the setting of positive surgical margins. | BMC Urol | 2018 Mar 5 | Shahait M | doi: 10.1186/s12894-018-0330-y. |
| 29758205 | Performance of P16/Ki67 dual staining in triaging hr-HPV-positive population during cervical Cancer screening in the younger women. | Clin Chim Acta | 2018 Aug | Qian QP | doi: 10.1016/j.cca.2018.05.023 |
| 29174711 | High immunoexpression of Ki67, EZH2, and SMYD3 in diagnostic prostate biopsies independently predicts outcome in patients with prostate cancer. | Urol Oncol | 2018 Apr | Lobo J | doi: 10.1016/j.urolonc.2017.10.028 |
| 28782638 | Prognostic value of programmed death ligand 1, p53, and Ki-67 in patients with advanced-stage colorectal cancer. | Hum Pathol | 2018 Jan | Wang L | doi: 10.1016/j.humpath.2017.07.014 |
| 30041599 | Mitotic count can predict tamoxifen benefit in postmenopausal breast cancer patients while Ki67 score cannot. | BMC Cancer | 2018 Jul 24 | Beelen K | doi: 10.1186/s12885-018-4516-1. |
| 29315957 | Apparent diffusion coefficients in prostate cancer: correlation with molecular markers Ki-67, HIF-1α and VEGF. | NMR Biomed | 2018 Mar | Ma T | doi: 10.1002/nbm.3884 |
| 29349711 | Impact of an embedded genetic counselor on breast cancer treatment. | Breast Cancer Res Treat | 2018 May | Pederson HJ | doi: 10.1007/s10549-017-4643-4 |
| 29516374 | Use of adjuvant chemotherapy in hormone receptor-positive breast cancer patients with or without the 21-gene expression assay. | Breast Cancer Res Treat | 2018 Jul | Park SJ | doi: 10.1007/s10549-018-4740-z |
| 30957671 | Clinical-pathological characteristics and short-term follow-up associated with proliferation, apoptosis and angiogenesis in a prospective cohort of patients with colorectal tumours. | Tumour Biol | 2019 Apr | Redondo M | doi: 10.1177/1010428319835684. |
